Oramed Pharmaceuticals
ORMP
ORMP
30 hedge funds and large institutions have $2.36M invested in Oramed Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.46% less ownership
Funds ownership: 4.83% → 4.38% (-0.46%)
20% less capital invested
Capital invested by funds: $2.94M → $2.36M (-$578K)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
30
Holding in Top 10
–
Calls
$357K
Puts
$48K
Top Buyers
| 1 | +$172K | |
| 2 | +$54.2K | |
| 3 | +$50K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$47K |
| 5 |
TI
Telemetry Investments
New York
|
+$32K |
Top Sellers
| 1 | -$539K | |
| 2 | -$64.5K | |
| 3 | -$46K | |
| 4 |
BlackRock
New York
|
-$8.47K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$6K |